Hervé Boutin

5.5k total citations
75 papers, 4.2k citations indexed

About

Hervé Boutin is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hervé Boutin has authored 75 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 29 papers in Neurology and 22 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hervé Boutin's work include Neuroinflammation and Neurodegeneration Mechanisms (27 papers), Neuroscience and Neuropharmacology Research (18 papers) and S100 Proteins and Annexins (16 papers). Hervé Boutin is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (27 papers), Neuroscience and Neuropharmacology Research (18 papers) and S100 Proteins and Annexins (16 papers). Hervé Boutin collaborates with scholars based in United Kingdom, France and United States. Hervé Boutin's co-authors include Nancy J. Rothwell, R.A. LeFeuvre, Masahide Asano, Yoichiro Iwakura, Fabien Chauveau, Reiko Horai, Bertrand Tavitian, Nadja Van Camp, Frédéric Dollé and Stuart M. Allan and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and NeuroImage.

In The Last Decade

Hervé Boutin

72 papers receiving 4.2k citations

Peers

Hervé Boutin
Jeffrey M. Gidday United States
Markus Kipp Germany
Karen Gertz Germany
Tim Magnus Germany
Huaxin Sheng United States
Hervé Boutin
Citations per year, relative to Hervé Boutin Hervé Boutin (= 1×) peers Myriam Bernaudin

Countries citing papers authored by Hervé Boutin

Since Specialization
Citations

This map shows the geographic impact of Hervé Boutin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Boutin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Boutin more than expected).

Fields of papers citing papers by Hervé Boutin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Boutin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Boutin. The network helps show where Hervé Boutin may publish in the future.

Co-authorship network of co-authors of Hervé Boutin

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Boutin. A scholar is included among the top collaborators of Hervé Boutin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Boutin. Hervé Boutin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, William J., Kelly Ceyzériat, Ben Dickie, et al.. (2025). Early metabolic changes in the brain of Alzheimer’s disease rats are driven by GLAST+ cells. Journal of Cerebral Blood Flow & Metabolism. 45(7). 1326–1342.
2.
Herholz, Karl, Adam McMahon, J. C. Thompson, et al.. (2024). Quantitative Imaging of Regional Cerebral Protein Synthesis in Clinical Alzheimer's Disease by [11C]Leucine PET. Molecular Imaging and Biology. 26(6). 977–985.
3.
Dickie, Ben, Tao Jin, Ping Wang, et al.. (2022). Quantitative kinetic modelling and mapping of cerebral glucose transport and metabolism using glucoCESL MRI. Journal of Cerebral Blood Flow & Metabolism. 42(11). 2066–2079. 4 indexed citations
4.
Harris, William J., Marie‐Claude Asselin, Rainer Hinz, et al.. (2022). In vivo methods for imaging blood–brain barrier function and dysfunction. European Journal of Nuclear Medicine and Molecular Imaging. 50(4). 1051–1083. 50 indexed citations
5.
Dickie, Ben, Hervé Boutin, Geoff J.M. Parker, & Laura M. Parkes. (2021). Alzheimer's disease pathology is associated with earlier alterations to blood–brain barrier water permeability compared with healthy ageing in TgF344‐AD rats. NMR in Biomedicine. 34(7). e4510–e4510. 29 indexed citations
6.
Chauveau, Fabien, Guillaume Becker, & Hervé Boutin. (2021). Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies. European Journal of Nuclear Medicine and Molecular Imaging. 49(1). 201–220. 35 indexed citations
7.
Legland, David, Ignacio Arganda‐Carreras, Françoise Peyrin, et al.. (2021). Brain virtual histology with X-ray phase-contrast tomography Part II: 3D morphologies of amyloid-β plaques in Alzheimer’s disease models. Biomedical Optics Express. 13(3). 1640–1640. 9 indexed citations
8.
Mampay, Myrthe, María Velasco‐Estevez, Aisling M. Chaney, et al.. (2020). Spatiotemporal immunolocalisation of REST in the brain of healthy ageing and Alzheimer’s disease rats. FEBS Open Bio. 11(1). 146–163. 6 indexed citations
9.
Dickie, Ben, et al.. (2018). Water-exchange MRI detects subtle blood-brain barrier breakdown in Alzheimer's disease rats. NeuroImage. 184. 349–358. 57 indexed citations
10.
Boutin, Hervé, Anthony Jones, Adam McMahon, et al.. (2017). Development of a method for the preparation of zirconium-89 radiolabelled chitosan nanoparticles as an application for leukocyte trafficking with positron emission tomography. Applied Radiation and Isotopes. 130. 7–12. 19 indexed citations
11.
Pradillo, Jesús M., Katie N. Murray, Graham Coutts, et al.. (2016). Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia. Brain Behavior and Immunity. 61. 117–126. 62 indexed citations
12.
Boutin, Hervé, C. Prenant, Renaud Maroy, et al.. (2013). [18F]DPA-714: Direct Comparison with [11C]PK11195 in a Model of Cerebral Ischemia in Rats. PLoS ONE. 8(2). e56441–e56441. 78 indexed citations
13.
Chauveau, Fabien, Nadja Van Camp, Frédéric Dollé, et al.. (2009). Comparative Evaluation of the Translocator Protein Radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a Rat Model of Acute Neuroinflammation. Journal of Nuclear Medicine. 50(3). 468–476. 194 indexed citations
14.
Chauveau, Fabien, Hervé Boutin, Nadja Van Camp, Frédéric Dollé, & Bertrand Tavitian. (2008). Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. European Journal of Nuclear Medicine and Molecular Imaging. 35(12). 2304–2319. 341 indexed citations
15.
Boutin, Hervé, Fabien Chauveau, Cyrille Thominiaux, et al.. (2007). 11C-DPA-713: A Novel Peripheral Benzodiazepine Receptor PET Ligand for In Vivo Imaging of Neuroinflammation. Journal of Nuclear Medicine. 48(4). 573–581. 136 indexed citations
16.
Chauveau, Fabien, Youssef Aissouni, Jörg Hamm, et al.. (2007). Binding of an aptamer to the N-terminal fragment of VCAM-1. Bioorganic & Medicinal Chemistry Letters. 17(22). 6119–6122. 12 indexed citations
17.
Boutin, Hervé, et al.. (2007). Long-term alterations in μ, δ and κ opioidergic receptors following middle cerebral artery occlusion in mice. Acta Neuropathologica. 114(5). 491–500. 16 indexed citations
18.
Patel, Hiren C., Hervé Boutin, & Stuart M. Allan. (2003). Interleukin‐1 in the Brain. Annals of the New York Academy of Sciences. 992(1). 39–47. 110 indexed citations
19.
Boutin, Hervé, Philippe Jauzac, Eric T. MacKenzie, & François Dauphin. (2003). Potential use of early alterations in μ and δ opioid receptors as a predictive index for delayed brain ischemic damage. Neurobiology of Disease. 13(1). 63–73. 6 indexed citations
20.
Craighead, Mark, Hervé Boutin, Stuart M. Allan, et al.. (2000). Influence of corticotrophin releasing factor on neuronal cell death in vitro and in vivo. Brain Research. 881(2). 139–143. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026